ProCE Banner Activity

CME

Expert Insights in Selecting a Switch Regimen for Virologically Suppressed HIV-Infected Patients

Multimedia
In this activity, Babafemi Taiwo, MBBS, presents a series of topical case studies featuring virologically suppressed patients with HIV infection who require a change in ART and discusses how our expert faculty chose to manage them.

Physicians : maximum of 0.75 AMA PRA Category 1 {Credit}

Released: March 12, 2018

Expiration: March 11, 2019

No longer available for credit.

Share

Faculty

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead

Target Audience

This program is intended for physicians and other healthcare providers who care for patients receiving antiretroviral therapy.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Integrate data from switch studies and expert guidelines into patient management strategies
  • Identify virologically suppressed patients who are appropriate candidates to consider a switch to a different antiretroviral regimen
  • Select individualized switch regimens that take account of all relevant patient and regimen factors to optimize safety, efficacy, and tolerability

Faculty Disclosure

Primary Author

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, and ViiV/GlaxoSmithKline and funds for research support from ViiV/GlaxoSmithKline.

Staff Disclosure

Staff

Jennifer M. Blanchette, Ph.D.

Clinical Editor
Clinical Care Options, LLC

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest to report.

Megan K. Murphy, PhD

Scientific Director

Megan K. Murphy, PhD, has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from March 12, 2018, through March 11, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve participants’ competence in evaluating which of their virologically suppressed patients should consider a switch in regimen and in selecting an optimal new regimen.